ZOLINZA
Active substance: vorinostat
CAPSULE · VORINOSTAT 100 mg/1
United StatesActive
Marketing holder: Merck Sharp & Dohme LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- VORINOSTAT · 100 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 2 | |
| EU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-4c4a-70e3-97dc-6d9b044297fe,01a120c5-a5c0-7545-9a10-76cf92d11328;count=2 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a12095-971b-728c-9fee-95449ca44c34;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0006-0568
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0006-0568 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0006-0568 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0006-0568 · Verified 2026-10-09 · open in source